The synthesis and characterization of a ditopic bridging ligand, 9,12,21,22-tetraazatetrapyrido[3,2-a:2',3'-c:3″2″-m:2''',3'''-o]pentaphene (tatppα) and its dinuclear ruthenium complex, [(phen)(2)Ru(tatppα)Ru(phen)(2)][PF(6)](4) (1(4+)), are described. The tatppα ligand is structurally very similar to 9,10,20,33-tetraazatetrapyrido[3,2-a:2',3'-c:3″,2″-l:2''',3'''-n]pentacene (tatppβ), except that, instead of a linear tetraazapentacene backbone, tatppα has an ortho (or α) substitution pattern about the central benzene ring, leading to a 120° bend. Complex 1(4+) shows tatppα-based reductions at -0.73 and -1.14 V vs Ag/AgCl/saturated KCl and has an absorption spectrum showing the typical Ru(II) dπ → phen-like π* metal-to-ligand charge-transfer transition centered at ∼450 nm. In acetonitrile, visible-light irradiation of 1(4+) in the presence of triethylamine leads to two sequential changes in the absorption spectra, which are assigned to the formation of the one- and two-electron-reduced species, with the electrons stored on the tatppα ligand. These assignments were made by comparison of the spectral changes observed in 1(4+) upon stoichiometric chemical reduction with cobaltocene and by spectroelectrochemical analysis. Significantly, DFT calculations are very predictive of the optical and reductive behavior of the tatppα complex relative to the tatppβ complexes and show that modeling is a useful tool for ligand design. The chemical reactivity and differential reflectance spectroelectrochemical data reveal that the reductions are accompanied by radical dimerization of the tatppα ligand to species such as σ-{1}(2)(6+), which is only slowly reversible upon exposure to air and may limit the complexe's 1(4+) utility for driving photochemical H(2) production.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ic2006698 | DOI Listing |
J Am Chem Soc
January 2025
Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing 100084, P. R. China.
Effective delivery and controlled release of metallo-prodrugs with sustained activation and rapid response feed the needs of precise medicine in metal chemotherapeutics. However, gold-based anticancer drugs often suffer from detoxification binding and extracellular transfer by sulfur-containing peptides. To address this challenge, we integrate a thiol-activated prodrug strategy of newly prepared hypercoordinated carbon-centered gold(I) clusters (HCGCs) with their photosensitization character to augment the mitochondrial release of Au(I) in tumors.
View Article and Find Full Text PDFTIGIT and PVRIG are immune checkpoints co-expressed on activated T and NK cells, contributing to tumor immune evasion. Simultaneous blockade of these pathways may enhance therapeutic efficacy, positioning them as promising dual targets for cancer immunotherapy. This study aimed to develop a bispecific antibody (BsAb) to co-target TIGIT and PVRIG.
View Article and Find Full Text PDFFront Immunol
January 2025
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
The innate immune system plays a critical role in the rapid recognition and elimination of pathogens through pattern recognition receptors (PRRs). Among these PRRs are the C-type lectins (CTLs) langerin, mannan-binding lectin (MBL), and surfactant protein D (SP-D), which recognize carbohydrate patterns on pathogens. Each represents proteins from different compartments of the body and employs separate effector mechanisms.
View Article and Find Full Text PDFInt J Cardiol Heart Vasc
February 2025
Department of Cardiovascular Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
Atrial fibrillation (AF) is the most common tachyarrhythmia and seriously affects human health. Key targets of AF bioinformatics analysis can help to better understand the pathogenesis of AF and develop therapeutic targets. The left atrial appendage tissue of 20 patients with AF and 10 patients with sinus rhythm were collected for sequencing, and the expression data of the atrial tissue were obtained.
View Article and Find Full Text PDFFront Chem
January 2025
African Society for Bioinformatics and Computational Biology, Cape Town, South Africa.
Introduction: Treatment of type 2 diabetes (T2D) remains a significant challenge because of its multifactorial nature and complex metabolic pathways. There is growing interest in finding new therapeutic targets that could lead to safer and more effective treatment options. Takeda G protein-coupled receptor 5 (TGR5) is a promising antidiabetic target that plays a key role in metabolic regulation, especially in glucose homeostasis and energy expenditure.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!